3 10/07/2024 31/10/2025 2025-10-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-07-10 Sage Accounts Production 25.0 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 15831946 2024-07-10 2025-10-31 15831946 2025-10-31 15831946 2024-07-09 15831946 bus:RegisteredOffice 2024-07-10 2025-10-31 15831946 bus:LeadAgentIfApplicable 2024-07-10 2025-10-31 15831946 bus:Director1 2024-07-10 2025-10-31 15831946 bus:Director2 2024-07-10 2025-10-31 15831946 bus:Director3 2024-07-10 2025-10-31 15831946 core:WithinOneYear 2025-10-31 15831946 core:AfterOneYear 2025-10-31 15831946 bus:Director1 2025-10-31 15831946 bus:Micro-entities 2024-07-10 2025-10-31 15831946 bus:AuditExemptWithAccountantsReport 2024-07-10 2025-10-31 15831946 bus:SmallCompaniesRegimeForAccounts 2024-07-10 2025-10-31 15831946 bus:PrivateLimitedCompanyLtd 2024-07-10 2025-10-31 15831946 bus:FullAccounts 2024-07-10 2025-10-31
Company registration number: 15831946
Resproin Limited
Unaudited filleted financial statements
31 October 2025
Resproin Limited
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
Resproin Limited
Directors and other information
Directors Mr Dharmesh Mehta (Appointed 10 July 2024)
Mr Jagdish Mehta (Appointed 10 July 2024)
Mrs Vasanti Jagdish Mehta (Appointed 10 July 2024)
Company number 15831946
Registered office 6th Floor
AMP House
Dingwall Road
Croydon
CR0 2LX
Accountants Doshi & Co. Accountants
6th Floor
AMP House
Dingwall Road
Croydon
CR0 2LX
Resproin Limited
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Resproin Limited
Period ended 31 October 2025
As described on the Statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the period ended 31 October 2025, as set out on pages 3 to 4.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Doshi & Co. Accountants
6th Floor
AMP House
Dingwall Road
Croydon
CR0 2LX
20 June 2026
Resproin Limited
Statement of financial position
31 October 2025
31/10/25
£
Fixed assets 368,540
_______
Current assets 4,458
Creditors: amounts falling due within one year ( 122,944)
_______
Net current liabilities ( 118,486)
_______
Total assets less current liabilities 250,054
Creditors: amounts falling due after more than one year ( 259,521)
_______
Net liabilities ( 9,467)
_______
Capital and reserves ( 9,467)
_______
Notes to the financial statements
Resproin Limited
Period ended 31 October 2025
1. Employee numbers
The average number of persons employed by the company during the period amounted to 3
2. Directors advances, credits and guarantees
During the period the directors entered into the following advances and credits with the company:
Period ended 31/10/25
Balance brought forward Amounts repaid Balance o/standing
£ £ £
Directors - ( 59,300) ( 59,300)
_______ _______ _______
For the period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 20 June 2026 , and are signed on behalf of the board by:
Mr Dharmesh Mehta
Director
Company registration number: 15831946
The company is a private company limited by shares, registered in England and Wales.